Enhancing Endovascular Procedures for Improved Clinical Outcomes.
FiberNet EPS
FDA cleared to capture and remove embolic material produced while performing percutaneous transluminal interventional procedures in carotid arteries with reference vessel diameters of 3.5 to 7.0mm.
Arch Protection System
Clinical evidence is emerging that suggests an increased risk of stroke is associated with emerging therapies such as trans-aortic valve implantation (TAVI). Lumen believes its platform technology has the ability to offer novel solutions to potentially improve patient outcomes for this and similar procedures.
Ischemic Stroke System
Stroke is the third leading cause of death and the leading cause of disability in the United States. Lumen believes its platform technology can be applied to develop a novel device designed to revascularize or open up a blood vessel that is blocked by a blood clot.